PRESS RELEASE published on 09/14/2023 at 07:30, 2 years 2 months ago PharmaSGP achieves top performance in the first half of 2023
PRESS RELEASE published on 06/29/2023 at 07:30, 2 years 5 months ago PharmaSGP Holding SE: Strong support at 2023 AGM for very successful business development
PRESS RELEASE published on 05/10/2023 at 07:30, 2 years 6 months ago PharmaSGP with a significant leap in revenue in Q1 2023 – EBITDA grows by more than 40%
PRESS RELEASE published on 04/19/2023 at 07:30, 2 years 7 months ago PharmaSGP plans dividend distribution of 49.2% after record year in 2022
PRESS RELEASE published on 03/15/2023 at 07:30, 2 years 8 months ago PharmaSGP confirms record revenue and record profitability for 2022 and publishes forecast for 2023
PRESS RELEASE published on 03/14/2023 at 18:17, 2 years 8 months ago EQS-Adhoc: PharmaSGP Holding SE releases forecast for full year 2023
PRESS RELEASE published on 02/20/2023 at 07:30, 2 years 9 months ago PharmaSGP achieves new record revenue of more than € 85.5 million for 2022 exceeding analysts’ expectations
PRESS RELEASE published on 01/03/2023 at 16:13, 2 years 11 months ago EQS-Adhoc: PharmaSGP Holding SE resolves on buyback program for own shares of up to 1.5 million Euro
Published on 12/05/2025 at 02:35, 2 hours 47 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 22 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 17 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 22 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 51 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 31 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 56 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 7 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 11 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 22 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 37 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 38 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 21 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
